The University of Technology Sydney has launched the ithree institute, focusing on the understanding and control of infectious diseases in humans and animals. [ + ]

A team of international researchers has published the results of a study showing a connection between erectile dysfunction and increased risk of heart disease. [ + ]

The phenomenon of ‘glycaemic memory’ has long puzzled diabetes clinicians and researchers. Now, researchers at the Baker Heart and International Diabetes Institute (Baker IDI) have made a crucial advance that explains how exposure to high blood-glucose levels drives epigenetic changes that underlie the syndrome. [ + ]

Like a spent fighter coming back from the brink after teetering on the ropes in the dying stages, the federal government’s R&D Tax Credit bill is still standing at the 12th round bell with only one more round to go. [ + ]

Australian scientists today paid tribute to the distinguished life and career of Professor Frank Fenner AC, MBE who passed away today aged 95. [ + ]

What triggers cancer? That is the question Melbourne scientist Dr Benjamin Kile is determined to answer.

Professor John Shine, Fellow of the Australian Academy of Science and Director of the Garvan Institute in Sydney, has won the 2010 Prime Minister's Prize for Science.

Shares in Sydney biotech Novogen jumped 16.7 percent today on news that its majority-owned US subsidiary Marshall Edwards had reported positive data from it anti-cancer therapeutic, NV-128. [ + ]

Researchers at the Baker IDI Heart and Diabetes Institute in Melbourne have released the results of an international patient trial of a novel new treatment based on radio waves which they say has the potential to revolutionise treatment for blood pressure and other conditions. [ + ]

Professor John Shine, Executive Director of Sydney’s Garvan Institute of Medical Research, received the 2010 Prime Minister’s Prize for Science, the nation’s most highly respected award for scientific achievement. [ + ]

Adelaide biotech Bionomics has reported positive data from a study of its anti-anxiety and depression drug BNC210, indicating a number of potential advantages over its many blockbuster rivals. [ + ]

Dr Benjamin Kile of the The Walter and Eliza Hall Institute has received the prestigious Science Minister’s Prize for Life Scientist of the Year for work in understanding the causes of cancer and for providing insight into the mechanisms that keep blood platelets alive. [ + ]

The results are in - young, tall and long-armed women are considered the most attractive according to a recent, cross-cultural study.

Twelve months after the release of the initial draft of the R&D Tax Credit, a series of false starts, contested claims and last minute legislative changes have seen the proposed 1 July 2010 start date come and go, with no resolution to the confusion in sight. [ + ]

There will be a $40 million investment collaboration between the Australian Government and the Medical Research Commercialisation Fund (MRCF) that promises to promote medical innovations through the difficult early stages of commercialisation.